The administration of a selective inhibitor of PI3Kγ reshaped the TME, promoted a macrophage polarization switch towards immunostimulatory programs that activated CD8 T cells, and mediated tumor regression, without having a direct effect on tumor cells. Here, CD8A is linked to neoplasm.